首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1415192篇
  免费   98245篇
  国内免费   2315篇
耳鼻咽喉   19972篇
儿科学   46195篇
妇产科学   41287篇
基础医学   206951篇
口腔科学   40261篇
临床医学   116139篇
内科学   282160篇
皮肤病学   30539篇
神经病学   110432篇
特种医学   53417篇
外国民族医学   367篇
外科学   213015篇
综合类   27184篇
现状与发展   1篇
一般理论   321篇
预防医学   108799篇
眼科学   32892篇
药学   108534篇
  1篇
中国医学   3040篇
肿瘤学   74245篇
  2018年   16115篇
  2017年   11598篇
  2016年   12716篇
  2015年   14531篇
  2014年   19393篇
  2013年   29540篇
  2012年   42253篇
  2011年   45192篇
  2010年   25807篇
  2009年   23499篇
  2008年   42451篇
  2007年   45956篇
  2006年   46234篇
  2005年   45106篇
  2004年   43164篇
  2003年   41681篇
  2002年   40925篇
  2001年   61778篇
  2000年   63666篇
  1999年   53842篇
  1998年   14832篇
  1997年   13231篇
  1996年   13456篇
  1995年   12694篇
  1994年   12041篇
  1992年   42723篇
  1991年   41869篇
  1990年   41416篇
  1989年   40008篇
  1988年   37374篇
  1987年   36496篇
  1986年   34908篇
  1985年   33226篇
  1984年   24718篇
  1983年   21487篇
  1982年   12740篇
  1981年   11249篇
  1979年   23602篇
  1978年   16538篇
  1977年   14364篇
  1976年   13579篇
  1975年   14933篇
  1974年   17566篇
  1973年   17015篇
  1972年   16207篇
  1971年   15119篇
  1970年   14035篇
  1969年   13626篇
  1968年   12887篇
  1967年   11282篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
The aim of the present study was to evaluate the antimicrobial activity of two synbiotic combinations, Lactobacillus fermentum with short-chain fructooligosaccharides (FOS-LF) and Bifidobacterium longum with isomaltooligosaccharides (IMO-BL), against enterohaemorrhagic Escherichia coli O157:H7 and enteropathogenic E. coli O86. Antimicrobial activity was determined (1) by co-culturing the synbiotics and pathogens in batch cultures, and (2) with the three-stage continuous culture system (gut model), inoculated with faecal slurry from an elderly donor. In the co-culture experiments, IMO-BL was significantly inhibitory to both E. coli strains, while FOS-LF was slightly inhibitory or not inhibitory. Factors other than acid production appeared to play a role in the inhibition. In the gut models, both synbiotics effectively inhibited E. coli O157 in the first vessel, but not in vessels 2 and 3. E. coli O86 was not significantly inhibited.  相似文献   
44.
45.
46.

Background

Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.

Materials and methods

Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.

Results

EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.

Conclusion

This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy.  相似文献   
47.
48.
49.
50.
BackgroundThe aim of this paper is to assess the current state of quality and outcomes measures being reported for hepatic resections in the recent literature.MethodsMedline and PubMed databases were searched for English language articles published between 1 January 2002 and 30 April 2013. Two examiners reviewed each article and relevant citations for appropriateness of inclusion, which excluded papers of liver donor hepatic resections, repeat hepatectomies or meta-analyses. Data were extracted and summarized by two examiners for analysis.ResultsFifty-five studies were identified with suitable reporting to assess peri-operative mortality in hepatic resections. In only 35% (19/55) of the studies was the follow-up time explicitly stated, and in 47% (26/55) of studies peri-operative mortality was limited to in-hospital or 30 days. The time period in which complications were captured was not explicitly stated in 19 out of 28 studies. The remaining studies only captured complications within 30 days of the index operation (8/28). There was a paucity of quality literature addressing truly patient-centred outcomes.ConclusionQuality outcomes after a hepatic resection are inconsistently reported in the literature. Quality outcome studies for a hepatectomy should report mortality and morbidity at a minimum of 90 days after surgery.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号